The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.
Acta Oncol
; 58(6): 897-900, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-30905251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purines
/
Antineoplastic Combined Chemotherapy Protocols
/
Fibromatosis, Aggressive
/
Adenomatous Polyposis Coli
/
Protein Kinase Inhibitors
/
Cyclin-Dependent Kinase 4
/
Cyclin-Dependent Kinase 6
/
Aminopyridines
/
Abdominal Neoplasms
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Acta Oncol
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
Finland